Shanghai Aohua Photoelectricity Endoscope Past Earnings Performance
Past criteria checks 1/6
Shanghai Aohua Photoelectricity Endoscope has been growing earnings at an average annual rate of 0.04%, while the Medical Equipment industry saw earnings growing at 5.5% annually. Revenues have been growing at an average rate of 25.6% per year. Shanghai Aohua Photoelectricity Endoscope's return on equity is 3.7%, and it has net margins of 6.7%.
Key information
0.04%
Earnings growth rate
-36.1%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | 25.6% |
| Return on equity | 3.7% |
| Net Margin | 6.7% |
| Next Earnings Update | 10 Apr 2025 |
Recent past performance updates
Recent updates
Shanghai Aohua Photoelectricity Endoscope Co., Ltd.'s (SHSE:688212) Price In Tune With Revenues
Dec 27
Shanghai Aohua Photoelectricity Endoscope (SHSE:688212) Might Be Having Difficulty Using Its Capital Effectively
Dec 04Earnings Troubles May Signal Larger Issues for Shanghai Aohua Photoelectricity Endoscope (SHSE:688212) Shareholders
Nov 01We Think Shanghai Aohua Photoelectricity Endoscope (SHSE:688212) Can Stay On Top Of Its Debt
Oct 18Estimating The Intrinsic Value Of Shanghai Aohua Photoelectricity Endoscope Co., Ltd. (SHSE:688212)
Sep 29Shanghai Aohua Photoelectricity Endoscope Co., Ltd.'s (SHSE:688212) Earnings Haven't Escaped The Attention Of Investors
May 31We Think That There Are Issues Underlying Shanghai Aohua Photoelectricity Endoscope's (SHSE:688212) Earnings
Apr 16Here's Why Shanghai Aohua Photoelectricity Endoscope (SHSE:688212) Has Caught The Eye Of Investors
Mar 17Revenue & Expenses Breakdown
How Shanghai Aohua Photoelectricity Endoscope makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 750 | 50 | 342 | 154 |
| 30 Jun 24 | 743 | 25 | 343 | 165 |
| 31 Mar 24 | 722 | 44 | 326 | 160 |
| 31 Dec 23 | 678 | 58 | 289 | 147 |
| 30 Sep 23 | 593 | 58 | 246 | 143 |
| 30 Jun 23 | 567 | 55 | 242 | 129 |
| 31 Mar 23 | 489 | 35 | 217 | 114 |
| 31 Dec 22 | 445 | 22 | 198 | 97 |
| 30 Sep 22 | 399 | 45 | 177 | 74 |
| 30 Jun 22 | 368 | 53 | 153 | 63 |
| 31 Mar 22 | 357 | 51 | 144 | 53 |
| 31 Dec 21 | 347 | 57 | 134 | 49 |
| 30 Sep 21 | 341 | 67 | 112 | 44 |
| 30 Jun 21 | 317 | 45 | 117 | 43 |
| 31 Mar 21 | 288 | 37 | 109 | 40 |
| 31 Dec 20 | 263 | 19 | 105 | 39 |
| 31 Dec 19 | 298 | 53 | 103 | 30 |
| 31 Dec 18 | 156 | -6 | 72 | 21 |
| 31 Dec 17 | 130 | -4 | 59 | 15 |
Quality Earnings: 688212 has a high level of non-cash earnings.
Growing Profit Margin: 688212's current net profit margins (6.7%) are lower than last year (9.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688212's earnings have grown by 0.04% per year over the past 5 years.
Accelerating Growth: 688212's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 688212 had negative earnings growth (-14.2%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).
Return on Equity
High ROE: 688212's Return on Equity (3.7%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 10:37 |
| End of Day Share Price | 2025/02/07 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shanghai Aohua Photoelectricity Endoscope Co., Ltd. is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jin Zhang | China International Capital Corporation Limited |
| Bo Yu | China International Capital Corporation Limited |
| Zhu Chen | Citic Securities Co., Ltd. |